Page
%P
-
Chapter and Conference Paper
Poor-Risk Acute Myelogenous Leukemia Patients Undergoing the Fludarabine – Cytosine Arabinoside – Filgrastim Regimen: Multidrug Resistance Expression, Granulocyte Colony-Stimulating Factor Priming Activity and Clinical Response
Eleven poor-risk acute myelogenous leukemia (AML) patients were treated with fludarabine + cytosine arabinoside + granulocyte colony-stimulating factor (FLAG). The median age was 38 (range 31–51 years) and fiv...
-
Chapter and Conference Paper
Preclinical Evaluation of Granulocyte-Macrophage Colony-Stimulating Factor/Interleukin 3 Fusion Protein (PIXY 321) in Acute Myeloid Leukemic Cells
Hemopoietic growth factors (GFs) can stimulate proliferation of leukemia cells, such effect furnished a rationale for acute myeloid leukemia (AML) treatment based on priming of quiescent blasts into cell cycle...
